Protagonist Therapeutics, Inc.PTGXNASDAQ
Loading
Revenue ContractionContracting
Percentile Rank82
3Y CAGR+20.1%
5Y CAGR+10.0%
Studio
Year-over-Year Change

Total revenue from sales of goods and services

3Y CAGR
+20.1%/yr
vs -3.7%/yr prior
5Y CAGR
+10.0%/yr
Recent acceleration
Acceleration
+23.8pp
Accelerating
Percentile
P82
Within normal range
vs 5Y Ago
1.6x
Solid growth
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
2025$46.02M-89.4%
2024$434.43M+624.1%
2023$60.00M+125.7%
2022$26.58M-2.8%
2021$27.36M-4.4%
2020$28.63M+12293.1%
2019$231000.00-99.3%
2018$30.93M+54.1%
2017$20.06M-
2016$0.00-